Edwards Lifesciences (EW) Gains from Sales and Divestitures (2013 - 2014)
Edwards Lifesciences' quarterly Gains from Sales and Divestitures came in at $200000.0 in Q4 2014, down 33.33% year-on-year from $300000.0 in Q4 2013, and down 33.33% quarter-over-quarter from $300000.0 in Q4 2013.
Edwards Lifesciences has reported Gains from Sales and Divestitures for 2 years, with the latest figure at $200000.0 in Q4 2014.
- For the quarter ending Q4 2014, Gains from Sales and Divestitures fell 33.33% year-over-year to $200000.0; the trailing twelve-month figure through Dec 2014 stood at $200000.0 (down 33.33% YoY), and the FY2014 full-year result was $200000.0, down 33.33% from the prior year.
- Gains from Sales and Divestitures for Q4 2014 stood at $200000.0, down from $300000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $300000.0 in Q4 2013, with the low at $200000.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 200,000.00 |
| Dec 31, 2014 | 200,000.00 |
| Dec 31, 2013 | 300,000.00 |
| Dec 31, 2013 | 300,000.00 |